Reviewing 2022 Advances in Childhood Interstitial Lung Disease and Non-CF Bronchiectasis
A year of research emphasizes the significance of collaboration, standardized approaches, and targeted therapies in rare pulmonary diseases.
Related Articles
Patients with Genetic HS Susceptibility Predisposed to Coronary Artery Disease, Diabetes
This analysis was conducted to evaluate whether genetic risk of hidradenitis suppurativa was linked to greater risk of future cardiometabolic disease.
Optimizing Use and Clinical Considerations for Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD
In part 2 of this 3-part series, Sperling and Gianos highlight the role of lipoprotein apheresis in contemporary settings and the supporting evidence base.
FDA Approves Sodium Oxybate for Cataplexy, Excessive Daytime Sleepiness in Pediatric Narcolepsy
Following the approval of sodium oxybate for cataplexy in adults with cataplexy, the FDA approves this indication for the pediatric population.
Exploring the Role, History of Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD
Laurence Sperling, MD, and Eugenia Gianos, MD, discuss the historical context and underutilization of lipoprotein apheresis in part 1 of a 3-part video series.
High Genetic Gout Risk Associated With Increased Risk of CVD
Adherence to a preventative, favorable lifestyle significantly reduced CVD risk in participants with high and low genetic risk.
FDA Extends Review of Obeticholic Acid (Ocaliva) sNDA for Primary Biliary Cholangitis
The FDA has extended its review of the sNDA, delaying the previous October 15, 2024, PDUFA date, without providing a new anticipated action date.
Tonix Pharma Submits NDA for TNX-102 SL, Potential Fibromyalgia Medication
Two pivotal phase 3 studies previously met their endpoints of significantly reducting daily pain compared with placebo.
Study Highlights Respiratory Tract Infection, Wheeze Risk Factors in Preterm-Born Infants
This review provides an overview of current data on immune development and risk factors for preterm-born infant development of respiratory infections and wheezing.
Policy Changes Boost Survival in Pediatric Liver Transplants
The study found that, following gradual policy changes, children with acute liver failure requiring a transplant now face a reduced risk of both mortality and…
Diabetes Dialogue: What to Know About the Eversense 365 CGM, with Brian Hansen
Brian Hansen, president of CGM at Ascensia Diabetes Care, joins the podcast to discuss the FDA clearance of the Eversense 365 CGM.